DPD testing for patients with cancer or kidney failure
Treatments studied
Part of Cancer, Digestive system, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This trial checks the activity of an enzyme called DPD before starting certain cancer treatments. Knowing your DPD level helps doctors decide if standard doses of chemotherapy are safe for you, especially if you also have kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be planning to start a fluoropyrimidine chemotherapy for breast or digestive cancer, or you are on dialysis or have serious kidney failure.
- You need to sign a consent form and have health insurance.
- You must not have severe anemia (hemoglobin below 8.5 g/dl) or very high LDH levels in your blood.
- You must not be in the exclusion period of another study or on the national volunteer file.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test that looks for cancer cells in your blood and checks if your tumor has a specific feature linked to DNA repair. The goal is to see if this blood test can help guide whether PARP inhibitor medicines—which target cancers with this feature—might work for you.
This trial uses a special test on your cancer cells to find which chemotherapy might work best for you. The aim is to treat advanced cancer that has caused fluid buildup in the chest or abdomen.
This trial tests a chemotherapy drug (trifluridine/tipiracil) in people with metastatic colorectal or gastroesophageal cancer who have a DPD deficiency. DPD deficiency means your body may have trouble breaking down certain chemotherapy drugs, which can lead to serious side effects. This study aims to see if this drug is safe and effective for you.
This trial checks if adjusting the dose of chemotherapy drugs 5-FU or capecitabine based on your DPYD genetic results can improve safety and effectiveness. It’s for people with cancer who are about to start these drugs for the first time.
This trial uses a lab test to see how your tumor responds to different drugs, helping doctors choose the best treatment for you. It is for people with pancreatic cancer (PDAC) who are having surgery or a biopsy.
This study is collecting information from people with chronic kidney disease and anemia who are taking a medication called daprodustat. The goal is to learn more about how well it works and how it affects patients in real life.
Hear when a new Renal Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.